The Diagnostic, Therapeutic and Prognostic Relevance of Neutrophil Extracellular Traps in Polytrauma.
DAMPs
Damage associated molecular patterns
NET
mitochondrial DNA
neutrophil extracellular traps
polytrauma
trauma
trauma centre
traumatic shock
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
07 Nov 2023
07 Nov 2023
Historique:
received:
03
08
2023
revised:
02
11
2023
accepted:
02
11
2023
medline:
27
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Neutrophil extracellular traps (NETs) represent a recently discovered polymorphonuclear leukocyte-associated ancient defence mechanism, and they have also been identified as part of polytrauma patients' sterile inflammatory response. This systematic review aimed to determine the clinical significance of NETs in polytrauma, focusing on potential prognostic, diagnostic and therapeutic relevance. The methodology covered all major databases and all study types, but was restricted to polytraumatised humans. Fourteen studies met the inclusion criteria, reporting on 1967 patients. Ten samples were taken from plasma and four from whole blood. There was no standardisation of methodology of NET detection among plasma studies; however, of all the papers that included a healthy control NET, proxies were increased. Polytrauma patients were consistently reported to have higher concentrations of NET markers in peripheral blood than those in healthy controls, but their diagnostic, therapeutic and prognostic utility is equivocal due to the diverse study population and methodology. After 20 years since the discovery of NETs, their natural history and potential clinical utility in polytrauma is undetermined, requiring further standardisation and research.
Identifiants
pubmed: 38002307
pii: biom13111625
doi: 10.3390/biom13111625
pmc: PMC10669581
pii:
doi:
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Crit Care. 2014 Dec;29(6):1133.e1-5
pubmed: 25128442
Front Immunol. 2018 Oct 02;9:2171
pubmed: 30356867
Ann Surg. 2017 Jun;265(6):1241-1249
pubmed: 27232244
Intensive Care Med Exp. 2019 May 22;7(1):29
pubmed: 31119471
J Trauma Acute Care Surg. 2023 Mar 1;94(3):361-370
pubmed: 36730076
J Clin Invest. 2019 Jun 17;129(7):2629-2639
pubmed: 31205028
Clin Chim Acta. 2021 Aug;519:231-238
pubmed: 34015302
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Cell Mol Immunol. 2019 Jan;16(1):19-27
pubmed: 29572545
J Clin Epidemiol. 2016 Jan;69:199-207.e2
pubmed: 26307459
Shock. 2022 Sep 1;58(3):231-235
pubmed: 36125357
Shock. 2022 Sep 1;58(3):217-223
pubmed: 35959777
PLoS One. 2016 Aug 16;11(8):e0161343
pubmed: 27529549
Clin Chim Acta. 2016 Aug 1;459:89-93
pubmed: 27259468
Crit Care Nurs Q. 1994 Aug;17(2):74-90
pubmed: 8055362
JCI Insight. 2023 Mar 22;8(6):
pubmed: 36802340
Shock. 2008 Oct;30(4):352-8
pubmed: 18317404
Vet Pathol. 2020 Jan;57(1):6-23
pubmed: 31342866
Int J Mol Sci. 2022 Dec 13;23(24):
pubmed: 36555464
Front Immunol. 2019 Apr 02;10:685
pubmed: 31001279
Shock. 2021 Sep 1;56(3):433-439
pubmed: 33534396
J Trauma Acute Care Surg. 2018 Aug;85(2):354-358
pubmed: 30080781
PLoS One. 2015 Mar 16;10(3):e0120549
pubmed: 25774524
Cardiovasc Res. 2022 Oct 21;118(13):2737-2753
pubmed: 34648022
Cancers (Basel). 2021 Sep 06;13(17):
pubmed: 34503307
Mediators Inflamm. 2012;2012:149560
pubmed: 22315507
Inj Prev. 2020 Oct;26(Supp 1):i96-i114
pubmed: 32332142